BBI

"Oncology is an exciting and vibrant sector. The scientists and technologists have been doing incredible things based upon the samples that they’re given, but there hasn’t been any particular movement in how the samples are prepared for years. Our msX platform has the potential to revolutionise how samples are collected, allowing for larger samples, faster extraction, simpler processing, and fully automatable capabilities."

"This investment is a strong endorsement of our team, technology, and vision. The early clinical data from our temporary device has given us real momentum, and with this funding, we’re excited to advance our permanent pacing platform, an innovation that could redefine how heart failure is treated."